ZYME - ZYMEWORKS ALERT: Bragar Eagel & Squire P.C. is Investigating Zymeworks Inc. on Behalf of Zymeworks Stockholders and Encourages Investors to Contact the Firm | Benzinga
NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Zymeworks Inc. ("Zymeworks" or the "Company") (NASDAQ:ZYME) on behalf of Zymeworks stockholders. Our investigation concerns whether Zymeworks has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On April 1, 2024, Zymeworks disclosed that it had removed Christopher Astle ("Astle") from the positions of Senior Vice President ("SVP") and Chief Financial Officer ("CFO"), effective immediately. Notably, although Zymeworks indicated ...